P998: TRETINOIN AND CALCITRIOL ENHANCE TREATMENT REGIMENS FOR JUVENILE MYELOMONOCYTIC LEUKEMIA IN EX VIVO DRUG SENSITIVITY ASSAYS

por Stieglitz, Elliot, Gu, Christine, Dhar, Anukriti, Huebner, Juwita, Ali, Kamran, Lacher, Markus
Publicado 2023

Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay

por Stieglitz, Elliot, Gu, Christine J., Richardson, Michelle, Kita, Ryosuke, Santaguida, Marianne T., Ali, Kamran A., Strachan, Debbie C., Dhar, Anukriti, Yam, George, Anderson, Wade, Anderson, Erica, Hübner, Juwita, Tasian, Sarah K., Loh, Mignon L., Lacher, Markus D.
Publicado 2023

ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors

por Wiedemeyer, Wolf R., Gavrilyuk, Julia, Schammel, Alexander, Zhao, Xi, Sarvaiya, Hetal, Pysz, Marybeth, Gu, Christine, You, Monica, Isse, Kumiko, Sullivan, Theodore, French, Dorothy, Lee, Christina, Dang, Angeline T., Zhang, Zhaomei, Aujay, Monette, Bankovich, Alexander J., Vitorino, Philip
Publicado 2022

Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML

por Strachan, Debbie C., Gu, Christine J., Kita, Ryosuke, Anderson, Erica K., Richardson, Michelle A., Yam, George, Pimm, Graham, Roselli, Jordan, Schweickert, Alyssa, Terrell, Maci, Rashid, Raushan, Gonzalez, Alan K., Oviedo, Hailey H., Alozie, Michelle C., Ilangovan, Tamilini, Marcogliese, Andrea N., Tada, Hiroomi, Santaguida, Marianne T., Stevens, Alexandra M.
Publicado 2022